Company Analysis Suven Life Sciences Limited
1. Summary
Advantages
- Price (236.03 βΉ) is less than fair price (259.45 βΉ)
- The stock's return over the last year (52.21%) is higher than the sector average (22.28%).
- Current debt level 0.2491% is below 100% and has decreased over 5 years from 3.66%.
Disadvantages
- Dividends (0%) are below the sector average (9.06%).
- The company's current efficiency (ROE=-32.56%) is lower than the sector average (ROE=10.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Suven Life Sciences Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.1% | 2.3% | 0.1% |
| 90 days | 93% | 12.4% | 5% |
| 1 year | 52.2% | 22.3% | 5.9% |
SUVEN vs Sector: Suven Life Sciences Limited has outperformed the "Healthcare" sector by 29.93% over the past year.
SUVEN vs Market: Suven Life Sciences Limited has outperformed the market by 46.32% over the past year.
Slightly volatile price: SUVEN is more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: SUVEN with weekly volatility of 1% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (236.03 βΉ) is lower than the fair price (259.45 βΉ).
Price not significantly lower than the fair price: The current price (236.03 βΉ) is slightly lower than the fair price by 9.9%.
4.2. P/E
P/E vs Sector: The company's P/E (200.45) is higher than that of the sector as a whole (59.52).
P/E vs Market: The company's P/E (200.45) is higher than that of the market as a whole (66.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.13) is higher than that of the sector as a whole (6.59).
P/BV vs Market: The company's P/BV (8.13) is higher than that of the market as a whole (6.6).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (187.81) is higher than that of the sector as a whole (9.3).
P/S vs Market: The company's P/S indicator (187.81) is higher than that of the market as a whole (18.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-21.98) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (-21.98) is lower than that of the market as a whole (24.96).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 2.3% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (2.3%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.49%).
5.4. ROE
ROE vs Sector: The company's ROE (-32.56%) is lower than that of the sector as a whole (10.54%).
ROE vs Market: The company's ROE (-32.56%) is lower than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (-31.19%) is lower than that of the sector as a whole (7.51%).
ROA vs Market: The company's ROA (-31.19%) is lower than that of the market as a whole (7.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (16.06%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (15.45%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '9.06%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
